European network for Health Technology Assessment, EUnetHTA: Planning, development, and implementation of a sustainable European network for Health Technology Assessment

Published on Dec 1, 2009in International Journal of Technology Assessment in Health Care1.418
· DOI :10.1017/S0266462309990754
Finn Børlum Kristensen13
Estimated H-index: 13
(University of Southern Denmark),
Marjukka Mäkelä31
Estimated H-index: 31
(National Institute for Health and Welfare)
+ 10 AuthorsJulia Chamova2
Estimated H-index: 2
(National Board of Health)
Objectives: The European network on Health Technology Assessment (EUnetHTA) aimed to produce tangible and practical results to be used in the various phases of health technology assessment and to establish a framework and processes to support this. This article presents the background, objectives, and organization of EUnetHTA, which involved a total of sixty-four partner organizations. Methods: Establishing an effective and sustainable structure for a transnational network involved many managerial, policy, and methodological tools, according to the objective of each task or Work Package. Transparency in organization, financial transactions, and decision making was a key principle in the management of the Project as was the commitment to appropriately involve stakeholders. Results: EUnetHTA activities resulted in a clear management and governance structure, efficient partnership, and transnational cooperation. The Project developed a model for sustainable continuation of the EUnetHTA Collaboration. Conclusions: The EUnetHTA Project achieved its goals by producing a suite of practical tools, a strong network, and plans for continuing the work in a sustainable EUnetHTA Collaboration that facilitates and promotes the use of HTA at national and regional levels. Responsiveness to political developments in Europe should be balanced with maintaining a high level of ambition to promote independent, evidence-based information and well-tested tools for best practice based on a strong network of HTA institutions.
  • References (12)
  • Citations (55)
📖 Papers frequently viewed together
54 Citations
79 Citations
12 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
73 CitationsSource
#1Lise Lund HåheimH-Index: 21
#2Iñaki Imaz (ISCIII: Carlos III Health Institute)H-Index: 6
Last. Berit MørlandH-Index: 7
view all 9 authors...
Objectives: The internal evaluation studied the development of the European network for Health Technology Assessment (EUnetHTA) Project in achieving the general objective of establishing an effective and a sustainable network of health technology assessment (HTA) in Europe. Methods: The Work Package 3 group was dedicated to this task and performed the work. Information on activities during the project was collected from three sources. First, three yearly cross-sectional studies surveyed the part...
3 CitationsSource
#1Camilla Palmhøj Nielsen (National Board of Health)H-Index: 7
#2Sarah Wadmann Lauritsen (National Board of Health)H-Index: 1
Last. Eva TurkH-Index: 2
view all 6 authors...
Objectives: This article explains how the issue of stakeholder involvement was addressed in the European network for Health Technology Assessment (EUnetHTA) Project and describes the structures of future stakeholder involvement in the EUnetHTA Collaboration. Methods: Initiatives led to a dialogue with stakeholders and exchanging views and expectations on health technology assessment (HTA) processes and the future development of EUnetHTA. The methods of involving different stakeholder groups in E...
21 CitationsSource
#1Finn Børlum Kristensen (University of Southern Denmark)H-Index: 13
#2Kristian LampeH-Index: 4
Last. Marie Louise Bistrup (National Board of Health)H-Index: 2
view all 11 authors...
Objectives: This article presents an overview of the practical methods and tools to support transnational Health Technology Assessment (HTA) that were developed and pilot tested by the European network for HTA (EUnetHTA), which involved a total of sixty-four Partner organizations. Methods: The methods differ according to scope and purpose of each of the tools developed. They included, for example, literature reviews, surveys, Delphi and consensus methods, workshops, pilot tests, and internal/pub...
54 CitationsSource
#2Nina Rehnqvist (KI: Karolinska Institutet)H-Index: 27
Last. Helena DahlgrenH-Index: 2
view all 4 authors...
Objectives: The aim of this study was to facilitate effective internal and external communication of an international network and to explore how to support communication and work processes in health technology assessment (HTA). Structure and Methods: European network for Health Technology Assessment (EUnetHTA) connected sixty-four HTA Partner organizations from thirty-three countries. User needs in the different steps of the HTA process were the starting point for developing an information syste...
5 CitationsSource
#1David Banta (UM: Maastricht University)H-Index: 14
#2Finn Børlum Kristensen (National Board of Health)H-Index: 4
Last. Egon Jonsson (U of A: University of Alberta)H-Index: 15
view all 3 authors...
This study summarizes the experience with health technology assessment (HTA) at the European level. Geographically, Europe includes approximately fifty countries with a total of approximately 730 million people. Politically, twenty-seven of these countries (500 million people) have come together in the European Union. The executive branch of the European Union is named the European Commission, which supports several activities, including research, all over Europe and in many other parts of the w...
30 CitationsSource
#1M. Hasan Rajab (A&M: Texas A&M University)H-Index: 11
#2Frank J. Villamaria (A&M: Texas A&M University)H-Index: 1
Last. J. J. Rohack (A&M: Texas A&M University)H-Index: 10
view all 3 authors...
Objectives: The aim of this study was to assess the status of translating research findings into practice at a major academic healthcare system in Central Texas. Methods: We conducted a cross-sectional survey addressing knowledge of and participation in translational research of physicians, residents, nurses and third- and fourth-year medical students in a major academic healthcare system in Central Texas. Results: Out of 508 respondents, 428 (84.3 percent) completed all questions. A total of 68...
3 CitationsSource
Political background As a German novelty, the Institute for Quality and Efficiency in Health Care (Institut fur Qualitat und Wirtschaftlichkeit im Gesundheitswesen; IGWiG) was established in 2004 to, among other tasks, evaluate the benefit of pharmaceuticals. In this context it is of importance that patented pharmaceuticals are only excluded from the reference pricing system if they offer a therapeutic improvement. The institute is commissioned by the Federal Joint Committee (Gemeinsamer Bundesa...
39 Citations
#1Egon Jonsson (KI: Karolinska Institutet)H-Index: 12
#2H. David BantaH-Index: 11
Last. Laura Sampietro-ColomH-Index: 14
view all 4 authors...
Health technology is an indispensable part of any nation's healthcare system. During the past 50 years, all member states that comprise the European Union have increased their technological base for health care, both in terms of knowledge and by investments in equipment, devices, and pharmaceuticals. Generally, this process has gone well. However, several problems have emerged related to the acquisition, diffusion, and use of modern health technology. Concerns have been also raised about the eff...
20 CitationsSource
The papers on the 16 European countries presented in this issue show their great diversity of health systems. Health technology assessment (HTA) has been institutionalized in a number of members of the European Union and has a growing impact on health policy. A remaining challenge is to see HTA visible and useful at the European level, which requires more active coordination of national and regional activities. A network of HTA programs and researchers has been established. The HTA-Europe Steeri...
10 CitationsSource
Cited By55
#1Bertalan NémethH-Index: 6
#2Wim Goettsch (UU: Utrecht University)H-Index: 27
Last. Zoltán Kaló (Semmelweis University)H-Index: 20
view all 9 authors...
Introduction: Lower income European countries have a worse health status and less funds for health care compared to Western Europe. Despite their limited human and financial capacities for conducti...
#1Steffen Haldrup (Novo Nordisk)H-Index: 2
#2Annunziata LapollaH-Index: 41
Last. Michael L. Wolden (Novo Nordisk)H-Index: 16
view all 4 authors...
AbstractAims: The costs associated with insulin therapy and diabetes-related complications represent a significant and growing economic burden for healthcare systems. The aim of this study was to e...
#1Ahmad Fasseeh (ELTE: Eötvös Loránd University)H-Index: 1
#2Rita Karam (Lebanese University)H-Index: 3
Last. Julia ChamovaH-Index: 2
view all 13 authors...
Introduction: Implementation of health technology assessment (HTA) is still in an early stage with some heterogeneity in the Middle East and North Africa (MENA). Our objective was to assess the current and future status of HTA implementation in the MENA region by focusing on regional commonalities. Methods: Preparatory discussions for the first ISPOR conference in the MENA region indicated some potentially generalizable trends of HTA roadmaps. To widen the perspective, a policy survey was conduc...
2 CitationsSource
#1Bengt Jönsson (HHS: Stockholm School of Economics)H-Index: 71
#2Grace HampsonH-Index: 4
Last. Olivier WongH-Index: 1
view all 6 authors...
Background Advanced therapy medicinal products (ATMPs) are beginning to reach European markets, and questions are being asked about their value for patients and how healthcare systems should pay for them.
3 CitationsSource
#1Songul Cinaroglu (Hacettepe University)H-Index: 3
#2Onur BaserH-Index: 29
This study intends to examine the main drivers of network relations among health technology assessment (HTA) organizations. Social network analysis was performed to determine the relations among HTA organizations and to visualize the main drivers of such collaboration. The members in HTA organizations such as International Society for Pharmacoeconomics and Outcomes Research, Health Technology Assessment international, International Network of Agencies for Health Technology Assessment, EuroScan, ...
#1Judit ErdösH-Index: 4
#2Sabine EttingerH-Index: 1
Last. Claudia WildH-Index: 17
view all 5 authors...
The European Network for Health Technology Assessment (EUnetHTA) was founded to support efficient production and use of health technology assessments (HTAs) across Europe by reducing redundancies through collaboration. To facilitate collaboration, a range of practical tools, methods and process definitions were developed. The article describes when and how these tools and methods are used along the HTA process with specific focus on “other technologies”, that is medical devices and non-pharmaceu...
Objectives: The HTA Core Model ® was developed to improve the transferability of health technology assessment (HTA) between settings. The model has been used by HTA agencies but is also of interest to manufacturers, for improving internal evidence generation and communicating with other HTA stakeholders. To establish if the model is fit for purpose from an industry perspective, the pharmaceutical company Roche, collaborating with the European Network for HTA (EUnetHTA), conducted an assessment o...
2 CitationsSource
#1Lisanne I. van Lier (VUmc: VU University Medical Center)H-Index: 2
#2Judith E. Bosmans (VU: VU University Amsterdam)H-Index: 22
Last. Henriëtte G. van der Roest (VUmc: VU University Medical Center)H-Index: 18
view all 10 authors...
Objectives Differences between country-specific guidelines for economic evaluations complicate the execution of international economic evaluations. The aim of this study was to develop cross-European recommendations for the identification, measurement and valuation of resource use and lost productivity in economic evaluations using a Delphi procedure.
5 CitationsSource
ABSTRACT Objectives To examine and compare the use of health technology assessment (HTA) for the reimbursement of new medicines in selected European Union member states with decades of experience in the use of HTA and in countries that have used it regularly since 2000. Methods The selected countries were categorized into “earlier” adopters (group A: England, Germany, France, and Sweden) and more “recent” adopters (group B: Poland, Bulgaria, Hungary, and Romania). A systematic review of publishe...
1 CitationsSource
#1Haijun Ma (Amgen)H-Index: 5
#2Estelle Russek-Cohen (FDA: Food and Drug Administration)H-Index: 3
Last. Qi Jiang (Amgen)H-Index: 5
view all 5 authors...
Background:Safety evaluation is a key aspect of medical product development. It is a continual and iterative process requiring thorough thinking, and dedicated time and resources.Methods:In this ar...
2 CitationsSource